Abstract:T lymphocytes are key players in the immune‐inflammatory response after a stroke. However, the distinct functioning of T cells in the damaged brain and the periphery requires further elucidation. By analyzing the potential biological significance of skewed TCR repertoire sequenced with high throughput, we found that both immunosuppression and enhanced antigen‐specific T‐cell response may exist in the periphery of acute ischemic stroke patients. These findings may benefit to identify targets for regulating neuroinflammation and the overall immune response after stroke, thereby offering potential avenues for therapeutic intervention. T lymphocytes play a vital role in the immune‐inflammatory response following a stroke. However, the specific mechanisms behind the contrasting functions of T cells in the brain and peripheral tissues after a stroke remain unclear and require further investigation. T‐cell receptors (TCRs) are essential in controlling how T lymphocytes develop and become active. This study aims to gain a deeper understanding of the biological function of T lymphocytes by analyzing the TCR repertoire in patients who have experienced an acute ischemic stroke (AIS). High‐throughput TCR sequencing was conducted on peripheral blood samples from 25 AIS patients and 10 healthy controls. We compared the percentage of T cells and the characteristics of the TCR repertoire, specifically focusing on the recombination of V(D)J gene fragments and the diversity of the complementarity determining region 3 (CDR3) of the Vβ gene. Additionally, this study analyzed the potential biological significance of the skewed TCR repertoire in AIS patients. In patients with AIS, the proportion of circulating lymphocytes (LY%) decreased while the systemic immune‐inflammatory index (SII) increased compared to healthy controls. The average number of TCR read pairs decreased, corresponding with the presence of lymphopenia. However, the recombination of V(D)J gene fragments, the number of CDR3 clonotypes, and the diversity of CDR3 was elevated in the peripheral blood of AIS patients. Furthermore, the increased number of CDR3 amino acid or nucleotide clonotypes was negatively correlated with neurologic deficits but positively correlated with AIS patients' systemic immune condition and functional outcomes. Our findings suggest that both immunosuppression and enhanced antigen‐specific T‐cell response may exist in the periphery of the AIS patients. Further investigation into the mechanisms underlying these opposing changes may lead to the discovery of novel targets to reverse immunosuppression or mitigate the detrimental effects of T cells in the lesioned brain of AIS patients.

Novel Subsets of Peripheral Immune Cells Associated with Promoting Stroke Recovery in Mice.

Immunoreactive Cells after Cerebral Ischemia

Coming to the Rescue: Regulatory T Cells for Promoting Recovery After Ischemic Stroke.

Sustained Increases in Immune Transcripts and Immune Cell Trafficking During the Recovery of Experimental Brain Ischemia.

Roles of Peripheral Immune Cells in the Recovery of Neurological Function after Ischemic Stroke

Communications Between Peripheral and the Brain-Resident Immune System in Neuronal Regeneration After Stroke

T Cells Modulate the Microglial Response to Brain Ischemia

Abstract 103: Acute Ischemia Induces Spatially and Transcriptionally Distinct Microglial Subclusters

Single-Cell Mapping of Brain Myeloid Cell Subsets Reveals Key Transcriptomic Changes Favoring Neuroplasticity after Ischemic Stroke.

Novel CH25H+ and OASL+ Microglia Subclusters Play Distinct Roles in Cerebral Ischemic Stroke

Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair after Ischemic Stroke

A novel phenotype of B cells associated with enhanced phagocytic capability and chemotactic function after ischemic stroke

Quantitative and Correlational Analysis of Brain and Spleen Immune Cellular Responses Following Cerebral Ischemia

Post-ischemic inflammatory response in the brain: Targeting immune cell in ischemic stroke therapy

Specific depletion of resident microglia in the early stage of stroke reduces cerebral ischemic damage

The characteristics of T‐cell receptor repertoire in relation to systemic immune response of patients with ischemic stroke

Long-Term Accumulation of T Cytotoxic 1, T Cytotoxic 17, and T Cytotoxic 17/1 Cells in the Brain Contributes to Microglia-Mediated Chronic Neuroinflammation After Ischemic Stroke

CCR2-dependent Monocytes/macrophages Exacerbate Acute Brain Injury but Promote Functional Recovery after Ischemic Stroke in Mice

Integrating spatial and single-cell transcriptomics to characterize the molecular and cellular architecture of the ischemic mouse brain

Systematic Study of the Immune Components after Ischemic Stroke Using CyTOF Techniques

Targeting Neutrophils As A Novel Therapeutic Strategy After Stroke